Aidarex Recalls Enalapril Maleate 2.5mg Due to Stability Issues
Aidarex Pharmaceuticals is recalling 11 bottles of Enalapril Maleate 2.5mg because out-of-specification degradation products were found during stability testing.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this recall as Class III, which by definition is unlikely to cause adverse health consequences, aligning with the 'Low' severity criteria for documentation or minor quality issues.
Plain-English summary
Aidarex Pharmaceuticals LLC is recalling 11 bottles of Enalapril Maleate, USP 2.5mg, 90-count bottles. The product is prescription-only and was distributed nationwide in the USA. The specific lots affected are 56698-1 (expiration date 1/31/2019) and 56698-2 (expiration date 4/30/2019).
The recall was initiated because out-of-specification results for the Enalapril Diketopiperazine degradation product were observed during commercial stability testing. This indicates that the medication may not meet quality standards over time.
Consumers who have this medication should contact their healthcare provider or pharmacist for guidance on how to proceed. The FDA has classified this recall as Class III, which means it is unlikely to cause adverse health consequences.
The recalled product
- Product
- Enalapril Maleate, USP 2.5MG, 90-count bottle, RX only. Packaged By: Aidarex Pharmaceuticals. Mfg: Wockhardt Ltd. India. NDC: 33261-0977-90
- Manufacturer
- Aidarex Pharmaceuticals LLC
- Category
- Drug — Prescription Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lots: 56698-1
- EXP 1/31/2019
- 56698-2
- EXP 4/30/2019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Aidarex Pharmaceuticals LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Aidarex Pharmaceuticals LLC
See all →- LowAidarex Recalls Enalapril Maleate Due to Out-of-Specification Degradation Product
FDA (Drugs) · 2018-08-01
- ModerateAidarex Recalls Enalapril Maleate Due to Out-of-Specification Degradation Product
FDA (Drugs) · 2018-08-01
- LowAidarex Recalls Ferrous Sulfate Tablets Due to Foreign Material Presence
FDA (Drugs) · 2018-05-23
- ModerateAidarex Recalls Enalapril Maleate Tablets Due to Impurity Failures
FDA (Drugs) · 2017-11-01
- LowAidarex Recalls Phentermine Capsules Due to Impurity Test Failures
FDA (Drugs) · 2017-09-20
Same hazard · quality defect
See all →- ModerateDicyclomine Hydrochloride Capsules Recalled for Empty Capsules
FDA (Drugs) · 2026-08-12
- ModerateMethohexital Sodium for Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-15
- ModerateMedline Lidocaine HCL Injection Ampules Recalled for Quality Issues
FDA (Devices) · 2026-07-08
- ModerateMedline Convenience Kits Block Tray recalled due to quality defects
FDA (Devices) · 2026-07-08
- ModerateMedline Ophthalmic Pack with Lidocaine Injection Kits Recalled
FDA (Devices) · 2026-07-08